MEDICAPS

MediCaps Share Price

₹44.28 +1.39 (3.24%)

19 May, 2025 15:53

SIP TrendupStart SIP in MEDICAPS

Start SIP

Performance

  • Low
  • ₹43
  • High
  • ₹45
  • 52 Week Low
  • ₹37
  • 52 Week High
  • ₹61
  • Open Price₹43
  • Previous Close₹43
  • Volume3,030

Investment Returns

  • Over 1 Month + 0.54%
  • Over 3 Month + 0.66%
  • Over 6 Month -12.89%
  • Over 1 Year -14.75%
SIP Lightning

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -16.4
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 55
  • P/B Ratio
  • 0.4
  • Average True Range
  • 2.79
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.44
  • RSI
  • 47.15
  • MFI
  • 21.44

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹44.28
+ 1.39 (3.24%)
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹43.13
  • 50 Day
  • ₹44.23
  • 100 Day
  • ₹45.94
  • 200 Day
  • ₹47.42

Resistance and Support

43.26 Pivot Speed
  • R3 46.50
  • R2 45.54
  • R1 44.22
  • S1 41.94
  • S2 40.98
  • S3 39.66

What's your outlook on MediCaps?

You can only vote for once

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-21 Audited Results
2025-02-12 Quarterly Results
2024-11-12 Quarterly Results
2024-08-07 Quarterly Results
2024-05-23 Quarterly Results

MediCaps F&O

MediCaps Shareholding Pattern

No data available.

About MediCaps

  • NSE Symbol
  • MEDICAPS
  • BSE Symbol
  • 523144
  • ISIN
  • INE442D01010

Similar Stocks to MediCaps

MediCaps FAQs

MediCaps share price is ₹44 As on 19 May, 2025 | 15:39

The Market Cap of MediCaps is ₹55.2 Cr As on 19 May, 2025 | 15:39

The P/E ratio of MediCaps is -16.4 As on 19 May, 2025 | 15:39

The PB ratio of MediCaps is 0.4 As on 19 May, 2025 | 15:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23